444 related articles for article (PubMed ID: 10555200)
21. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
Kanda Y; Mineishi S; Saito T; Saito A; Yamada S; Ohnishi M; Chizuka A; Niiya H; Suenaga K; Nakai K; Takeuchi T; Makimoto A; Tanosaki R; Kami M; Tanaka Y; Fujita S; Watanabe T; Kobayashi Y; Tobinai K; Takaue Y
Bone Marrow Transplant; 2001 Oct; 28(7):689-92. PubMed ID: 11704792
[TBL] [Abstract][Full Text] [Related]
22. [Acyclovir therapy in varicella/zoster diseases in immunocompromised children with cancer].
Kuhn N; Landbeck G
Monatsschr Kinderheilkd; 1984 Feb; 132(2):105-9. PubMed ID: 6328285
[TBL] [Abstract][Full Text] [Related]
23. Compartmentalization of acyclovir-resistant varicella zoster virus: implications for sampling in molecular diagnostics.
Brink AA; van Gelder M; Wolffs PF; Bruggeman CA; van Loo IH
Clin Infect Dis; 2011 Apr; 52(8):982-7. PubMed ID: 21460310
[TBL] [Abstract][Full Text] [Related]
24. Detection of varicella-zoster virus DNA in peripheral mononuclear cells from patients with Ramsay Hunt syndrome or zoster sine herpete.
Terada K; Niizuma T; Kawano S; Kataoka N; Akisada T; Orita Y
J Med Virol; 1998 Dec; 56(4):359-63. PubMed ID: 9829642
[TBL] [Abstract][Full Text] [Related]
25. Use of genomic analysis of varicella-zoster virus to investigate suspected varicella-zoster transmission within a renal unit.
Molyneaux PJ; Parker S; Khan IH; Millar CG; Breuer J
J Clin Virol; 2006 May; 36(1):76-8. PubMed ID: 16545596
[TBL] [Abstract][Full Text] [Related]
26. [Acyclovir therapy of varicella-zoster virus infections in the immunosuppressed children ].
Peyramond D; Denoyel GA; Bertrand JL; Bertoye A
Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):596-602. PubMed ID: 6750532
[TBL] [Abstract][Full Text] [Related]
27. Two cases of varicella zoster virus meningitis found in pediatric patients after bone marrow transplantation despite valaciclovir prophylaxis and without skin lesions.
Lévêque N; Galambrun C; Najioullah F; Bleyzac N; Pages MP; Bertrand Y
J Med Virol; 2006 Apr; 78(4):514-6. PubMed ID: 16482541
[TBL] [Abstract][Full Text] [Related]
28. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
[TBL] [Abstract][Full Text] [Related]
29. [Antiviral drug therapy of infections caused by Herpes simplex and Varicella Zoster viruses].
Vogt M; Huss R; Wunderli W
Schweiz Med Wochenschr; 1992 Apr; 122(16):569-75. PubMed ID: 1579862
[TBL] [Abstract][Full Text] [Related]
30. Emerging drugs for varicella-zoster virus infections.
Andrei G; Snoeck R
Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
[TBL] [Abstract][Full Text] [Related]
31. Characterization of viremia at different stages of varicella-zoster virus infection.
Mainka C; Fuss B; Geiger H; Höfelmayr H; Wolff MH
J Med Virol; 1998 Sep; 56(1):91-8. PubMed ID: 9700639
[TBL] [Abstract][Full Text] [Related]
32. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child.
Levin MJ; Dahl KM; Weinberg A; Giller R; Patel A; Krause PR
J Infect Dis; 2003 Oct; 188(7):954-9. PubMed ID: 14513413
[TBL] [Abstract][Full Text] [Related]
33. Current therapy of varicella zoster virus infection in immunocompromised patients. A comparison of acyclovir and vidarabine.
Shepp DH; Dandliker PS; Meyers JD
Am J Med; 1988 Aug; 85(2A):96-8. PubMed ID: 3044102
[TBL] [Abstract][Full Text] [Related]
34. Antiviral therapy for varicella and herpes zoster.
Arvin AM
Semin Pediatr Infect Dis; 2002 Jan; 13(1):12-21. PubMed ID: 12118839
[TBL] [Abstract][Full Text] [Related]
35. [Varicella-zoster virus].
Saint-Léger E; Fillet AM
Rev Prat; 1999 Dec; 49(20):2208-16. PubMed ID: 10731804
[TBL] [Abstract][Full Text] [Related]
36. Herpes zoster in a 2-year-old vaccinated against varicella.
Ulman CA; Trevino JJ; Gandhi RK
Dermatol Online J; 2014 Jan; 20(1):21259. PubMed ID: 24456962
[TBL] [Abstract][Full Text] [Related]
37. Severe meningoencephalitis due to late reactivation of Varicella-Zoster virus in an immunocompetent child.
Spiegel R; Miron D; Lumelsky D; Horovitz Y
J Child Neurol; 2010 Jan; 25(1):87-90. PubMed ID: 19494359
[TBL] [Abstract][Full Text] [Related]
38. Acyclovir prophylaxis against varicella zoster virus reactivation in multiple myeloma patients treated with bortezomib-based therapies: a retrospective analysis of 100 patients.
Swaika A; Paulus A; Miller KC; Sher T; Almyroudis NG; Ball D; Wood M; Masood A; Lee K; Chanan-Khan AA
J Support Oncol; 2012; 10(4):155-9. PubMed ID: 22222250
[TBL] [Abstract][Full Text] [Related]
39. DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine.
Gomi Y; Ozaki T; Nishimura N; Narita A; Suzuki M; Ahn J; Watanabe N; Koyama N; Ushida H; Yasuda N; Nakane K; Funahashi K; Fuke I; Takamizawa A; Ishikawa T; Yamanishi K; Takahashi M
Vaccine; 2008 Oct; 26(44):5627-32. PubMed ID: 18706951
[TBL] [Abstract][Full Text] [Related]
40. Prevention and treatment of VZV infections in patients with HIV.
Gershon AA
Herpes; 2001 Jul; 8(2):32-6. PubMed ID: 11867015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
